Here’s Why SGA Global Growth Fund Sold Its Stake in UnitedHealth (UNH)

Summary

SGA Global Growth Strategy exited its stake in UnitedHealth Group in Q1 2026, citing disappointing CMS rate proposals, membership losses, and slower-than-expected profitability improvement at Optum. The fund reallocated capital into higher-conviction growth opportunities.

Market Impact

The decision reflects heightened caution around Medicare Advantage headwinds and competitive pressures, which could weigh on UnitedHealth's near-term growth. The stock's 32.70% gain over 52 weeks may face pressure as hedge fund holdings dropped from 145 to 130 funds quarter-over-quarter.

Why It Matters

UnitedHealth is a bellwether for the managed care sector, and its challenges with Medicare Advantage rate cuts and execution missteps signal broader industry risks tied to regulatory changes and market maturation.

Key Points

• SGA exited UnitedHealth due to CMS preliminary rate of 0.1% for 2027 (later revised to 2.5%), below expectations.
• Membership losses and slower Optum profitability improvement indicate a more mature, competitive Medicare Advantage market.
• Hedge fund holdings decreased from 145 to 130 funds in Q1 2026.
• UnitedHealth reported Q1 2026 revenues of $111.7 billion, up 2% YoY.

Key Entities

Evidence

While we acknowledge the potential of UnitedHealth Group Incorporated (NYSE:UNH) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk.

Supports: SGA's shift in capital allocation away from UNH to AI stocks

According to our database, 130 hedge fund portfolios held UnitedHealth Group Incorporated (NYSE:UNH) at the end of the first quarter, compared to 145 in the previous quarter.

Supports: Decrease in hedge fund interest in UNH

In Q1 2026, UnitedHealth Group Incorporated (NYSE:UNH) reported revenues of nearly $111.7 billion, representing a 2% increase from Q1 2025.

Supports: Revenue growth but below potential due to challenges